Market News - Page 558

J D Wetherspoon plc ('J D Wetherspoon' or 'the Company') announces its Q2 business update. The Company's interim results for the six months ending 26 January 2020 are expected to be announced on 20 March 2020.

…

Melrose Industries Plc, the British buyout specialist, is considering selling the bulk of its Nortek division
…

Harworth Group plc (“Harworth” or “the Group”), a leading regenerator of land and property for development and investment, today provides a trading update for the financial year ended 31 December 2019….

Camellia Plc announces the following trading update for the year ended 31 December 2019….

BHP Group issue operation review for the half-year ended 31 December 2019…

Further to recent press speculation, intu properties plc (“intu” or the “Company”) continues to make progress in its strategy to fix the balance sheet….

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US for patients with metastatic castration-resistant prostate cancer (mCRPC) and deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene mutations, who have progressed following prior treatment with a new hormonal agent….

AstraZeneca's Imfinzi (durvalumab) and tremelimumab, an anti-CTLA4 antibody and potential new medicine, have both been granted Orphan Drug Designation (ODD) in the US for the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

…